Resumen documental de ASEM
Official National Advisory Committee on Immunization document (2024) on “Archived: Summary of NACI statement of March 8, 2024: Updated guidance on the use of protein subunit COVID-19 vaccine (Novavax Nuvaxovid)”. Valid as of March 8, 2024: Summary of the National Advisory Committee on Immunization's recommendations for the updated guidance on the use of protein subunit COVID-19 vaccine (Novavax Nuvaxovid).
Este resumen facilita la identificación del documento. Para consultar recomendaciones clínicas, consulte siempre la versión oficial vigente y su fecha de actualización.
Documento oficial